Stockscreener 앱 받기
103.05
0.12%
-0.12
시간 외 거래:
103.05
전일 마감가:
$103.17
열려 있는:
$103
하루 거래량:
8.52M
Relative Volume:
1.18
시가총액:
$152.69B
수익:
$18.49B
순이익/손실:
$2.50B
주가수익비율:
61.34
EPS:
1.68
순현금흐름:
$3.49B
1주 성능:
+0.29%
1개월 성능:
-0.57%
6개월 성능:
-2.18%
1년 성능:
+31.69%
1일 변동 폭
$102.18
$103.36
1주일 범위
$101.62
$104.65
52주 변동 폭
$77.71
$108.53
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
103.05 | 152.87B | 18.49B | 2.50B | 3.49B | 1.68 |
|
ABT
Abbott Laboratories
|
130.27 | 229.31B | 43.11B | 13.94B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
381.61 | 146.01B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.81 | 119.18B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.30 | 45.95B | 5.69B | 1.41B | 577.90M | 6.95 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance
Insider Selling Trends in Nasdaq-Listed Companies: A Cautionary Lens on Alnylam, Boston Scientific, and CSX - AInvest
Jefferies Reiterates a Buy Rating on Boston Scientific Corporation (BSX), Sets a $130 PT - ca.finance.yahoo.com
Boston Scientific Tumbles 0.94% as Volume Dives 26.54% to 186th Despite IBD Rating Surge to 71 - AInvest
Former FDA Director, Boston Scientific Leaders Join Keyron’s Board - Medical Product Outsourcing
12 Best Stocks to Invest in For Beginners - Insider Monkey
FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads - Insider Monkey
Stock Analysis | Boston Scientific OutlookTechnical Weakness and Mixed Analyst Signals - AInvest
Boston Scientific Watchman device procedure risk - Yahoo Finance
Is Boston Scientific Corporation trending in predictive chart modelsBull Run & AI Based Buy and Sell Signals - Newser
Is now a turning point for Boston Scientific Corporation2025 EndofYear Setup & Verified Momentum Stock Alerts - Newser
Boston Scientific's 196th Trading Volume Rank Amid Strategic Shifts Mixed Analyst Outlooks and Contradictory Technical Signals - AInvest
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Boston Scientific Insider Transactions Raise Concerns Over Past Year - AInvest
Possible Bearish Signals With Boston Scientific Insiders Disposing Stock - ca.finance.yahoo.com
Is Boston Scientific (BSX) Ready to Break Out Again After Reaching an All-Time High? - AInvest
Fund Update: FLPUTNAM INVESTMENT MANAGEMENT CO added 95,234 shares of BOSTON SCIENTIFIC ($BSX) to their portfolio - Quiver Quantitative
3 Reasons Growth Investors Will Love Boston Scientific (BSX) - Yahoo Finance
Jefferies Keeps Their Buy Rating on Boston Scientific (BSX) - The Globe and Mail
US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD - Yahoo Finance
Wall Street Favorite J&J Snack Foods Faces Risks, Hanesbrands' Sales Flatline, Boston Scientific Sees Continued Growth - AInvest
Exit strategy if you’re trapped in Boston Scientific CorporationFree Investment Playbook for Growing Markets - Newser
How high can Boston Scientific Corporation stock goFree Buy Alerts With Low Risk Confirmation - Newser
BOSTON SCIENTIFIC CORPORATION (BSX) - MSN
Boston Scientific Corporation Is Expensive But Worth It - Seeking Alpha
Is Boston Scientific (NYSE:BSX) a Compounding Machine with Sustainable Growth and Attractive Risk-Reward Profile? - AInvest
Boston Scientific (NYSE:BSX) Is Experiencing Growth In Returns On Capital - ca.finance.yahoo.com
FDA issues alert for updated instructions for certain Boston Scientific Watchman access systems - MassDevice
Boston Scientific updates instructions of devices linked to 17 deaths - MedTech Dive
Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue - Yahoo Finance
FDA says Watchman access alert remedied by review of IFU - BioWorld MedTech
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths - MSN
Q2 Medical Devices & SuppliesDiversified Earnings: Boston Scientific (NYSE:BSX) Earns Top Marks - ca.finance.yahoo.com
Boston Scientific tells users about defibrillator problem linked to deaths, injuries - MedTech Dive
Oppenheimer Lifts Boston Scientific (BSX) PT to $118 Following Strong Q2 Results - Insider Monkey
Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to Know - Yahoo Finance
Boston Scientific survey reveals weight loss struggles among women, launches Endura procedures - MassDevice
Boston Scientific stock falls after FDA discloses defibrillation lead issue - Investing.com
Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions - Yahoo Finance
CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in Austin - The Globe and Mail
BSX Stock Quote Price and Forecast - CNN
Boston Scientific Corporation Could See a Relief Rally From SupportDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
0.05%
자본화:
|
볼륨(24시간):